Skip to main content
Avivagen Inc. logo

Avivagen Inc. — Investor Relations & Filings

Ticker · VIV ISIN · CA05382F2026 TSXV Manufacturing
Open in API
Filings indexed 552 across all filing types
Latest filing 2021-06-08 Investor Presentation
Country CA Canada
Listing TSXV VIV

About Avivagen Inc.

http://www.avivagen.com

Avivagen Inc. was a life sciences corporation focused on developing and commercializing natural health products for livestock, companion animals, and humans. The company specialized in feed additives designed to support immune function and promote growth in animals, emphasizing science-based validation through clinical trials. On April 23, 2024, Avivagen Inc. filed a voluntary assignment in bankruptcy, and a trustee was appointed to manage the proceedings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Investor Presentation Classification · 85% confidence The document is a press release announcing Avivagen's upcoming presentation at the LD Micro Conference on June 10, 2021. It provides details about the event, the company's technology, and contact information. There is no financial data, no report attached or referenced as being published, and no regulatory filing or certification. The content is clearly an investor presentation announcement rather than the presentation itself or a financial report. Given the nature of the document as an announcement of a presentation event, the most appropriate classification is Investor Presentation (IP). However, since the document is announcing the presentation rather than containing the presentation materials, it could be considered a Report Publication Announcement (RPA). But the document is more about the presentation event itself, which aligns with Investor Presentation (IP). The document length is under 5,000 characters, but it does not state that a report is attached or published, so it is not RPA. Therefore, the best fit is Investor Presentation (IP).
2021-06-08 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the proposed extension of warrants and the grant of stock options to an officer and director. It discusses the terms of the warrants, the need for approval from the TSX Venture Exchange, and the issuance of options as part of a remuneration package. There is no detailed financial data, no comprehensive financial report, no earnings results, no management discussion of financial results, nor any regulatory filing or certification. The content focuses on capital structure changes related to warrants and options. Therefore, this document fits best under the category of Capital/Financing Update (CAP). The document length is about 5,269 characters, which is sufficient for a substantive announcement but not a full report. Hence, the classification is CAP with high confidence.
2021-06-07 English
News release - English.pdf
Regulatory Filings
2021-06-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2021-06-02 English
Interim MD&A - English.pdf
Regulatory Filings
2021-06-02 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-06-02 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.